Anika Therapeutics Inc (ANIK)

Stock-Based Compensation

$13.15M

TTM · Period ending: · USD

ANIK logo

ANIK Stock-Based Compensation

Latest reported$13.15M
ANIK TTM Stock-Based Comp ($0.00 → $13.15M)
High-resolution chart · PNG

ANIK stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Anika Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
13,147,000
13,862,000
10,084,000
9,881,000
11,060,000
12,403,000
9,540,000
11,100,000
11,267,000
7,376,000
11,093,000
11,091,000
11,406,000
15,487,000
14,315,000
13,668,000
9,792,000
8,508,000
8,222,000
5,056,000
6,976,000
4,179,000
1,920,000
1,920,000
1,311,000
2,754,000
4,140,000
5,122,000
4,988,000
4,867,000
11,046,000
11,931,000
12,229,000
12,190,000
5,807,000
5,056,000
4,379,000
3,757,000
3,392,000
2,938,609
2,639,051
2,487,403
2,225,000
1,973,451
1,865,588
1,734,195
1,607,421
1,307,502
1,285,526
1,272,934
1,268,070
1,394,125
1,306,452
1,253,648
1,151,199
1,203,081
1,241,463
1,210,932
1,190,697
1,168,651
1,138,346
1,100,334
1,102,617
1,086,221
1,049,647
1,060,226
958,025
1,842,921
1,590,488
1,335,889
1,458,821
912,039,289
912,039,289
912,039,289
911,716,000
1,267,205,000
1,267,205,000
1,267,205,000
1,267,205,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,876,000
3,876,000
3,876,000
3,876,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.